ABBV Looks 15.8% Overvalued on GF Value™ with Dividend Sustainability in Focus
gurufocus.com · 2026-09-11
On September 11, 2026, AbbVie Inc (NYSE: ABBV) announced it will maintain its quarterly dividend at $1.73 per share, reflecting a forward dividend yield of appr
TickrTrends take: ABBV's current TickrTrends assessment of being fairly valued contrasts with the GF Value metric cited in the headline, suggesting different valuation methodologies are reaching different conclusions about the stock. For investors focused on valuation, the divergence between these assessments highlights the importance of monitoring which metrics are driving any repricing, particularly given the headline's emphasis on dividend sustainability as a key concern. In the Healthcare sector where ABBV operates, dividend stability and valuation alignment often move together, making the interaction between these two factors a critical watch point for value-conscious investors.
Read the full story at gurufocus.com →
Is ABBV undervalued? See TickrTrends' fair value analysis →